1Kent P,O' Donoghue JM,O' Hanlon DM,et al.Linkage analysis and the susceptibility gene (BRCA-1) in familial breast cancer[J].Eur J Surg Oncol,1995,21 (3):240-241.
2Stolier AJ,Fuhrman GM,Mauterer L,et al.Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation[J].Breast J,2004,10(6):475 -480.
3Veronesi A,de Giacomi C,Magri MD,et al.Familial breast cancer:characteristics and outcome of BRCA 1-2 positive and negative cases[J].BMC Cancer,2005,5(70):1 -6.
4Wirk B.The role of ovarian ablation in the management of breast cancer[J].Breast J,2005,11 (6):416-424.
6Shastry BS.SNPs and haplotypes:genetic markers for disease and drug response (review)[J].Int J Mol Med,2003,11 (3):379 -382.
7Guerra E,Vacca G,Palombo B,et al.Prognostic value of mutations in TP53 and RAS genes in breast cancer[J].Int J Biol Markers,2003,18(1):49 -53.
8Miyakis S,Sourvinos G,Spandidos DA.Differential expression and mutation of the ras family genes in human breast cancer[J].Biochem Biophys Res Commun,1998,251 (2):609 -612.
9Ziyaie D,Hupp TR,Thompson AM.P53 and breast cancer[J].Breast,2000,9 (5):239-246.
10Yamauchi H,Stearns V,Hayes DF.The Role of c-erbB-2 as a predictive factor in breast cancer[J].Breast Cancer,2001,8(3):171 -183.
